Julia Krämer Tanja Krömer-Olbrisch Heinz-Jürgen Lakomek Peter D Schellinger Dirk Foell Sven G Meuth Vera Straeten
10.3389/fimmu.2020.02099
Front Immunol
2020 Aug 28;11:2099.
adult onset still disease alemtuzumab anakinra case report multiple sclerosis rituximab secondary autoimmunity
CC BY
https://pubmed.ncbi.nlm.nih.gov/33013884/
Alemtuzumab / administration & dosage Alemtuzumab / adverse effects Multiple Sclerosis / drug therapy Multiple Sclerosis / immunology Multiple Sclerosis / pathology Still's Disease, Adult-Onset / chemically induced Still's Disease, Adult-Onset / immunology Still's Disease, Adult-Onset / pathology
Alemtuzumab / administration & dosage Alemtuzumab / adverse effects Multiple Sclerosis / drug therapy Multiple Sclerosis / immunology Multiple Sclerosis / pathology Still's Disease, Adult-Onset / chemically induced Still's Disease, Adult-Onset / immunology Still's Disease, Adult-Onset / pathology Case Reports Adult Female Humans Alemtuzumab
PMC7493652
33013884
Case Report: Adult Still's Disease in an Alemtuzumab-Treated Multiple Sclerosis Patient
2020